Keep up to date with news from Gamma Gurus — Featured

Gamma Gurus is proudly B-Corp certified. Certified B Corporations are leaders in the global movement for an inclusive, equitable, and regenerative economy. Unlike our other certifications, such as ISO9001 and ISO 17025, this uniquely measures a company’s entire social and environmental impact.

Gamma Gurus is very pleased to announce the signing of an agency agreement with Bruker BioSpin to market their portfolio of Nuclear Molecular Imaging (NMI) products in Australia & New Zealand. This expands our ability to support the preclinical NMI field by adding additional products, including PET/MR, to the already successful Molecubes range that was acquired by Bruker in November 2021. We look forward to introducing these new products to our customers in 2023!

Louvain-La-Neuve, Belgium, 26 August, 2022 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the treatment of cancer, today announces that the Company is the only proton therapy equipment supplier that has qualified for the second round of a significant public tender launched by the Spanish Ministry of Health. This public tender is aimed at selecting one or several proton therapy suppliers to install 10 proton therapy units across the country. The Spanish Ministry of Health has published the results of the first round of selection of the...

RadTat is the first non-invasive, semi-permanent skin marking for radiation oncology and Gamma Gurus is pleased to be able to offer this innovative product in Australia. RadTats were designed with both patients and providers in mind as a simple and painless alternative to permanent tatoos that will last for up to two weeks with little to no maintenance by patient or care provider. This is not a sticker! RadTat provides a quick, simple solution that lasts! RadTat Semi-permanent Skin Marking – Gamma Gurus

The ConformalFLASH® Alliance will be the first collaboration platform between academia and industry to bring ConformalFLASH® proton therapy to the clinic  Louvain-la-Neuve, Belgium, June 30, 2022 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology, announces today the launch of the ConformalFLASH®1 Alliance, which aims to accelerate the delivery of ConformalFLASH® Proton Therapy to patients.  ConformalFLASH® is a novel delivery technique combining ultra-high dose rate FLASH radiotherapy with the unique Bragg Peak properties of protons. These ultra-high dose rates create the opportunity to optimize and accelerate the radiotherapy process and increase the therapeutic ratio.2  ...